Transjugular Intrahepatic Portosystemic Shunts: Advances and New Uses in Patients with Chronic Liver Disease

Justin R. Boike; Steven L. Flamm

doi:10.1016/j.cld.2020.04.007

Transjugular Intrahepatic Portosystemic Shunts: Advances and New Uses in Patients with Chronic Liver Disease

Justin R. Boike^*, Steven L. Flamm

^*Corresponding author for this work

Medicine, Hepatology Division

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

Transjugular intrahepatic portosystemic shunts is an established treatment for portal hypertensive complications. Advancements in technology and technique have led to novel indications, including treatment of chronic portal vein thrombosis and use before abdominal surgery to alleviate portal hypertensive complications. Use of TIPS can facilitate the embolization of large portal-systemic shunts to alleviate refractory hepatic encephalopathy owing to excessive portal shunting. Despite these advances, transjugular intrahepatic portosystemic shunts is an invasive procedure with risk for complications and should be performed at a center with expertise to ensure a successful patient outcome.

Original language	English (US)
Pages (from-to)	373-388
Number of pages	16
Journal	Clinics in liver disease
Volume	24
Issue number	3
DOIs	https://doi.org/10.1016/j.cld.2020.04.007
State	Published - Aug 2020

Funding

Dr J. Boike receives investigator-initiated grant support from W. L. Gore & Associates , the Manufacturer of the TIPS Viatorr® stent .

Keywords

Ascites
Hepatopulmonary syndrome
Hepatorenal syndrome
Portal hypertension
Portal vein thrombosis
Spontaneous portal systemic shunts
Transjugular intrahepatic portosystemic shunt
Varices

ASJC Scopus subject areas

Hepatology

Access to Document

10.1016/j.cld.2020.04.007

Cite this

@article{a638eff2f42f4cd580046656cebd1a30,

title = "Transjugular Intrahepatic Portosystemic Shunts: Advances and New Uses in Patients with Chronic Liver Disease",

abstract = "Transjugular intrahepatic portosystemic shunts is an established treatment for portal hypertensive complications. Advancements in technology and technique have led to novel indications, including treatment of chronic portal vein thrombosis and use before abdominal surgery to alleviate portal hypertensive complications. Use of TIPS can facilitate the embolization of large portal-systemic shunts to alleviate refractory hepatic encephalopathy owing to excessive portal shunting. Despite these advances, transjugular intrahepatic portosystemic shunts is an invasive procedure with risk for complications and should be performed at a center with expertise to ensure a successful patient outcome.",

keywords = "Ascites, Hepatopulmonary syndrome, Hepatorenal syndrome, Portal hypertension, Portal vein thrombosis, Spontaneous portal systemic shunts, Transjugular intrahepatic portosystemic shunt, Varices",

author = "Boike, {Justin R.} and Flamm, {Steven L.}",

note = "Funding Information: Dr J. Boike receives investigator-initiated grant support from W. L. Gore & Associates , the Manufacturer of the TIPS Viatorr{\textregistered} stent . Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2020",

month = aug,

doi = "10.1016/j.cld.2020.04.007",

language = "English (US)",

volume = "24",

pages = "373--388",

journal = "Clinics in liver disease",

issn = "1089-3261",

publisher = "W.B. Saunders",

number = "3",

}

TY - JOUR

T1 - Transjugular Intrahepatic Portosystemic Shunts

T2 - Advances and New Uses in Patients with Chronic Liver Disease

AU - Boike, Justin R.

AU - Flamm, Steven L.

N1 - Funding Information: Dr J. Boike receives investigator-initiated grant support from W. L. Gore & Associates , the Manufacturer of the TIPS Viatorr® stent . Publisher Copyright: © 2020 Elsevier Inc.

PY - 2020/8

Y1 - 2020/8

N2 - Transjugular intrahepatic portosystemic shunts is an established treatment for portal hypertensive complications. Advancements in technology and technique have led to novel indications, including treatment of chronic portal vein thrombosis and use before abdominal surgery to alleviate portal hypertensive complications. Use of TIPS can facilitate the embolization of large portal-systemic shunts to alleviate refractory hepatic encephalopathy owing to excessive portal shunting. Despite these advances, transjugular intrahepatic portosystemic shunts is an invasive procedure with risk for complications and should be performed at a center with expertise to ensure a successful patient outcome.

AB - Transjugular intrahepatic portosystemic shunts is an established treatment for portal hypertensive complications. Advancements in technology and technique have led to novel indications, including treatment of chronic portal vein thrombosis and use before abdominal surgery to alleviate portal hypertensive complications. Use of TIPS can facilitate the embolization of large portal-systemic shunts to alleviate refractory hepatic encephalopathy owing to excessive portal shunting. Despite these advances, transjugular intrahepatic portosystemic shunts is an invasive procedure with risk for complications and should be performed at a center with expertise to ensure a successful patient outcome.

KW - Ascites

KW - Hepatopulmonary syndrome

KW - Hepatorenal syndrome

KW - Portal hypertension

KW - Portal vein thrombosis

KW - Spontaneous portal systemic shunts

KW - Transjugular intrahepatic portosystemic shunt

KW - Varices

UR - http://www.scopus.com/inward/record.url?scp=85085622756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085622756&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2020.04.007

DO - 10.1016/j.cld.2020.04.007

M3 - Review article

C2 - 32620278

AN - SCOPUS:85085622756

SN - 1089-3261

VL - 24

SP - 373

EP - 388

JO - Clinics in liver disease

JF - Clinics in liver disease

IS - 3

ER -

Transjugular Intrahepatic Portosystemic Shunts: Advances and New Uses in Patients with Chronic Liver Disease

Abstract

Funding

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this